Ascend Wellness Holdings (AAWH) Current Assets (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Current Assets of $189.0 million for Q1 2026, down 20.39% year-over-year from $237.4 million in Q1 2025, and down 9.56% quarter-over-quarter from $208.9 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Current Assets (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Current Assets history runs 7 years deep, the most recent figure standing at $189.0 million for Q1 2026.
- In Q1 2026, Current Assets fell 20.39% year-over-year to $189.0 million; the TTM figure through Mar 2026 stood at $189.0 million (down 20.39% YoY), while the FY2025 annual figure was $208.9 million, down 8.91% from the prior year.
- Current Assets for Q1 2026 stood at $189.0 million, down from $208.9 million in the prior quarter.
- The five-year high for Current Assets was $260.6 million in Q1 2022, with the low at $189.0 million in Q1 2026.
- The 5-year median for Current Assets is $219.1 million (2022), against an average of $222.2 million.
- Peak annual rise in Current Assets reached 84.7% in 2022, while the deepest fall reached 26.89% in 2022.
- Ascend Wellness Holdings' Current Assets stood at $198.7 million in 2022, then advanced by 15.15% to $228.9 million in 2023, then climbed by 0.23% to $229.4 million in 2024, then retreated by 8.91% to $208.9 million in 2025, then retreated by 9.56% to $189.0 million in 2026.
- Business Quant data shows AAWH's Current Assets at $189.0 million in Q1 2026, $208.9 million in Q4 2025, and $209.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.22 Bn |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 186.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 186.87 Mn |
| Mar 31, 2026 | 188.96 Mn |
| Dec 31, 2025 | 208.95 Mn |
| Sep 30, 2025 | 209.21 Mn |
| Jun 30, 2025 | 225.65 Mn |
| Mar 31, 2025 | 237.38 Mn |
| Dec 31, 2024 | 229.38 Mn |
| Sep 30, 2024 | 213.58 Mn |
| Jun 30, 2024 | 236.26 Mn |
| Mar 31, 2024 | 232.04 Mn |
| Dec 31, 2023 | 228.86 Mn |
| Sep 30, 2023 | 211.33 Mn |
| Jun 30, 2023 | 213.14 Mn |
| Mar 31, 2023 | 204.21 Mn |
| Dec 31, 2022 | 198.74 Mn |
| Sep 30, 2022 | 219.09 Mn |
| Jun 30, 2022 | 259.95 Mn |
| Mar 31, 2022 | 260.55 Mn |
| Dec 31, 2021 | 258.01 Mn |
| Sep 30, 2021 | 299.67 Mn |